Arthur J. Gallagher & Co. Announces Regular Second Quarter Dividend
PR Newswire
ROLLING MEADOWS, Ill., April 26, 2023 /PRNewswire/ -- Arthur J. Gallagher & Co. (NYSE: AJG) today declared a regular quarterly cash dividend of fifty five cents ($0.55) per share on the Common Stock of the Company, payable on June 16, 2023 to Stockholders of Record as of June 2, 2023.
Arthur J. Gallagher & Co. (NYSE: AJG), a global insurance brokerage, risk management and consulting services firm, is headquartered in Rolling Meadows, Illinois. Gallagher provides these services in approximately 130 countries around the world through its owned operations and a network of correspondent brokers and consultants.
Contact: Ray Iardella VP – Investor Relations 630-285-3661/[email protected]
AMERISAFE Announces 2023 First Quarter Results
First Mid Bancshares, Inc. Announces First Quarter 2023 Results
Advisor News
- Finseca and IAQFP announce merger
- More than half of recent retirees regret how they saved
- Tech group seeks additional context addressing AI risks in CSF 2.0 draft profile connecting frameworks
- How to discuss higher deductibles without losing client trust
- Take advantage of the exploding $800B IRA rollover market
More Advisor NewsAnnuity News
- Somerset Re Appoints New Chief Financial Officer and Chief Legal Officer as Firm Builds on Record-Setting Year
- Indexing the industry for IULs and annuities
- United Heritage Life Insurance Company goes live on Equisoft’s cloud-based policy administration system
- Court fines Cutter Financial $100,000, requires client notice of guilty verdict
- KBRA Releases Research – Private Credit: From Acquisitions to Partnerships—Asset Managers’ Growing Role With Life/Annuity Insurers
More Annuity NewsHealth/Employee Benefits News
- When health insurance costs more than the mortgage
- As ACA subsidies expire, thousands drop coverage or downgrade plans
- Findings from Centers for Disease Control and Prevention Provides New Data about Managed Care (Association Between Health Plan Design and the Demand for Naloxone: Evidence From a Natural Experiment in New York): Managed Care
- Medicare is experimenting with having AI review claims – a cost-saving measure that could risk denying needed care
- CMS proposed rule impacts MA marketing and enrollment
More Health/Employee Benefits NewsLife Insurance News